RoundTable Healthcare Partners has made an investment in Colorescience, a premium skincare and sun protection brand known for mineral-based, clinically validated products and broad-spectrum protection. Terms of the transaction were not disclosed.
Colorescience, headquartered in Carlsbad, California, has built distribution across professional channels, direct-to-consumer, and major e-commerce platforms. The company is positioned to expand brand awareness, deepen channel penetration, and broaden its product portfolio while maintaining its clinical and science-driven positioning, according to the announcement.
RoundTable said the investment aligns with its consumer healthcare focus and marks its ninth such investment. The firm acquired Colorescience from a group of shareholders led by 1315 Capital.
Support: The deal was financed with senior debt led by Capital One, N.A. as sole lead arranger and administrative agent, alongside CIBC Bank USA and Lord Abbett Private Credit Advisor LLC. Sidley Austin served as legal counsel to RoundTable. Raymond James advised on the transaction, and Greenberg Traurig served as legal counsel to Colorescience.
KEY QUOTES
“Since 2013, our team has built Colorescience into a trusted brand that delivers meaningful protection and performance for our customers. I want to sincerely thank our employees for their passion and dedication in helping us reach this exciting point in our evolution. We are thrilled to partner with RoundTable as we enter the next stage of growth, and we believe their values, culture, and operating expertise align closely with what makes Colorescience special.”
Mary Fisher, Chief Executive Officer, Colorescience
“We could not be more excited to partner with Mary and the entire Colorescience management team. Colorescience has built a compelling platform defined by strong consumer advocacy and a differentiated product portfolio anchored by a commitment to science and innovation. We look forward to supporting the team as they continue to advance the Colorescience brand and capitalize on the Company’s momentum.”
Tim Connors, Managing Partner, RoundTable Healthcare Partners; Chairman of the Board, Colorescience
“Colorescience represents our ninth consumer healthcare platform investment, and further reinforces RoundTable’s commitment to partnering with management teams to build enduring, category-leading businesses with brands that are both expert-recommended and consumer-preferred. We believe our dedicated operating resources, channel expertise, and experience supporting practitioner-oriented brands position us well to help the Company accelerate growth and better serve its customers.”
Jawwad Akhtar, Partner, RoundTable Healthcare Partners
“It has been a privilege to work alongside the Colorescience team as the Company focused on protecting and saving lives through its high-performing skincare and sun protection products. Our firm has partnered with RoundTable on multiple transactions and has been consistently impressed with their operational focus. The growth of Colorescience over the past few years has been tremendous, and we are excited about RoundTable’s impact on the trajectory ahead.”
Adele Oliva, Founding Partner, 1315 Capital
